We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-0.83%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$3.01B
Cap. Flow
+$3.35B
Cap. Flow %
30.64%
Top 10 Hldgs %
32.26%
Holding
2,911
New
179
Increased
662
Reduced
956
Closed
673

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Industrials 9.07%
3 Financials 5.38%
4 Consumer Discretionary 4.16%
5 Healthcare 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COLD icon
1001
Americold
COLD
$4.05B
$194K ﹤0.01%
16,900
-5,212
-24% -$65.3K
IBKR icon
1002
Interactive Brokers
IBKR
$41.2B
$193K ﹤0.01%
2,877
-1,050
-27% -$74.9K
BEP icon
1003
Brookfield Renewable
BEP
$10B
$187K ﹤0.01%
5,731
+1
+0% +$30
LFUS icon
1004
Littelfuse
LFUS
$10.4B
$185K ﹤0.01%
544
+284
+109% +$92.2K
XHB icon
1005
State Street SPDR S&P Homebuilders ETF
XHB
$1.74B
$184K ﹤0.01%
1,865
-25
-1% -$2.74K
GPC icon
1006
Genuine Parts
GPC
$17B
$184K ﹤0.01%
1,739
-312
-15% -$38.6K
SBAC icon
1007
SBA Communications
SBAC
$18.6B
$181K ﹤0.01%
1,054
+559
+113% +$105K
XRP
1008
Bitwise XRP ETF
XRP
$246M
$180K ﹤0.01%
+12,000
New +$217K
CMS icon
1009
CMS Energy
CMS
$23.1B
$175K ﹤0.01%
2,257
-859
-28% -$63.8K
BC icon
1010
Brunswick
BC
$5.23B
$175K ﹤0.01%
2,404
-240
-9% -$19.4K
FXE icon
1011
Invesco CurrencyShares Euro Currency Trust
FXE
$331M
$175K ﹤0.01%
1,638
SRPT icon
1012
Sarepta Therapeutics
SRPT
$1.67B
$174K ﹤0.01%
8,000
+1,815
+29% +$35.1K
HXL icon
1013
Hexcel
HXL
$8.26B
$174K ﹤0.01%
2,149
+1,332
+163% +$112K
MBB icon
1014
iShares MBS ETF
MBB
$39B
$174K ﹤0.01%
1,831
+688
+60% +$65.7K
TDS icon
1015
Telephone and Data Systems
TDS
$3.95B
$173K ﹤0.01%
4,100
DDFD
1016
Innovator Equity Dual Directional 15 Buffer ETF Dec
DDFD
$106M
$170K ﹤0.01%
8,981
RSMC
1017
Rockefeller U.S. Small-Mid Cap ETF
RSMC
$752M
$170K ﹤0.01%
6,835
-4,035
-37% -$105K
PEG icon
1018
Public Service Enterprise Group
PEG
$39.8B
$169K ﹤0.01%
2,084
-1,398
-40% -$115K
CTRA
1019
DELISTED
Coterra Energy
CTRA
$168K ﹤0.01%
4,771
-18,580
-80% -$559K
AUTL
1020
Autolus Therapeutics
AUTL
$399M
$167K ﹤0.01%
121,107
LION icon
1021
Lionsgate Studios
LION
$3.92B
$167K ﹤0.01%
17,364
DYNF icon
1022
BlackRock US Equity Factor Rotation ETF
DYNF
$38.3B
$165K ﹤0.01%
+2,835
New +$172K
DGX icon
1023
Quest Diagnostics
DGX
$25.2B
$164K ﹤0.01%
835
-1,001
-55% -$194K
SOLS
1024
Solstice Advanced Materials
SOLS
$9.72B
$164K ﹤0.01%
2,147
-655
-23% -$44.9K
FV icon
1025
First Trust Dorsey Wright Focus 5 ETF
FV
$3.64B
$163K ﹤0.01%
2,704

Similar funds

Clearstead Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Clearstead Advisors held 2,911 positions worth $10.9B, up 38% from $7.93B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Clearstead Advisors deployed $3.35B of net new capital in Q1 2026, opening 179 new positions and adding to 662 existing holdings. Its largest new stake was Dimensional International High Profitability ETF: 5,528,400 shares worth $178M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, down from 12% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $37.5M trimmed.

  • Clearstead Advisors's largest Q1 2026 buy was Dimensional International High Profitability ETF: 5,528,400 shares worth $178M.
  • Clearstead Advisors added most to PACCAR in Q1 2026, an estimated $588M increase.
  • Clearstead Advisors's biggest Q1 2026 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $37.5M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $732M.
  • Clearstead Advisors's ten largest holdings make up 32% of its $10.9B portfolio in Q1 2026.
  • Clearstead Advisors opened 179 new positions and closed 673 in Q1 2026.
  • Clearstead Advisors's portfolio value rose 38% quarter-over-quarter to $10.9B.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.